Search Results - "Troost, E.G.C."

The role of functional imaging for radiation oncology – The whole translational chain from animals to clinics by Troost, E.G.C

Get full text

Single organ metastatic disease and local disease status, prognostic factors for overall survival in stage IV non-small cell lung cancer: Results from a population-based study by Hendriks, L.E, Derks, J.L, Postmus, P.E, Damhuis, R.A, Houben, R.M.A, Troost, E.G.C, Hochstenbag, M.M, Smit, E.F, Dingemans, A.-M.C

“…Highlights • OS significantly longer in single organ metastatic disease compared to 2 or ⩾3 organs. • Single organ metastases also prognostic in subgroup of18…”
Get full text

OC-0252: Accurate prediction of PTV and OAR doses for doseescalation of non-small cell lung cancer patients by Petit, S, Troost, E.G.C, Van Elmpt, W

Get full text

PO-0679: Comparison of toxicity and outcome in stage III NSCLC patients treated with IMRT or VMAT by Wiisman, R, Dankers, F, Troost, E.G.C, Hoffmann, A.L, Bussink, J

Get full text

SP-0061: Head and neck cancer: FDG imaging and beyond by Hoeben, B.A.w, Bussink, J, Troost, E.G.C, Oyen, W.J.G, Kaanders, J.H.A.M

Get full text

PO-0661: Multivariable predictive modeling of acute esophageal toxicity after IMRT for advanced stage NSCLC by Wijsman, R, Dankers, F, Troost, E.G.C, Hoffmann, A.L, Bussink, J

Get full text

PO-0678: Do blood-biomarkers enhance clinical models for NSCLC patients treated with radical radiotherapy? by Carvalho, S, Troost, E.G.C, Bons, J, Menheere, P, Lambin, P, Oberije, C

Get full text

Prospective Validation of a Prognostic Computed Tomography–Based Radiomic Signature in Stage IV Non-Small Cell Lung Cancer by de Jong, E, van Elmpt, W, Leijenaar, R.T.H, Carvalho, S, Troost, E.G.C, Hendriks, L.E.L, Dingemans, A.M.C, Lambin, P

Get full text

Patients’ needs in proton therapy: A survey among ten European facilities by Mazzola, G.C., Bergamaschi, L., Pedone, C., Vincini, M.G., Pepa, M., Zaffaroni, M., Volpe, S., Rombi, B., Doyen, J., Fossati, P., Haustermans, K., Høyer, M., Langendijk, J.A., Matute, R., Orlandi, E., Rylander, H., Troost, E.G.C., Orecchia, R., Alterio, D., Jereczek-Fossa, B.A.

“…•Proton therapy (PT) is a resource-limited approach due to the low number of available PT facilities.•Aim is to investigate logistic/economic support…”
Get full text

PO-0941: Adaptive radiotherapy based on integrated transit planar dosimetry for lung cancer patients by Persoon, L.C.G.G, Sanizadeh, A, De Ruiter, B, Nijsten, S, Verhaegen, F, Troost, E.G.C

Get full text

OC-0262: Comparison of machine-learning methods for predictive radiomic models in locally advanced HNSCC by Leger, S, Bandurska-Luque, A, Pilz, K, Zöphel, K, Baumann, M, Troost, E.G.C, Löck, S, Richter, C

Get full text

158: Time resolved portal dosimetry for Volumetric Modulated Arc Therapy (VMAT) in lung cancer patients with atelectasis by Podesta, M, Persoon, L.C.G.G, Nijsten, S.M.J.J.G, Troost, E.G.C, Verhaegen, F

Get full text

61P PHYSICO-BIOLOGICAL TREATMENT PLAN OPTIMIZATION FOR INDIVIDUALIZED DOSE ESCALATION IN ADVANCED NON-SMALL CELL LUNG CANCER RADIOTHERAPY: MAXIMALLY ACHIEVABLE TUMOR DOSE VERSUS RISK OF RADIATION PNEUMONITIS by Troost, E.G.C, Hoffmann, A.L, Bussink, J, Kaanders, J.H.A.M

Get full text

Time- and dose-dependent volume decreases in subcortical grey matter structures of glioma patients after radio(chemo)therapy by Raschke, F., Witzmann, K., Seidlitz, A., Wesemann, T., Jentsch, C., Platzek, I., van den Hoff, J., Kotzerke, J., Beuthien-Baumann, B., Baumann, M., Linn, J., Krause, M., Troost, E.G.C.

“…•Radiotherapy causes atrophy of the hippocampus, amygdala, putamen, thalamus and pallidum.•Atrophy is dose dependant and progressive over time.•The hippocampus…”
Get full text

OC-0059: Validated clinical model for survival prediction after stereotactic radiotherapy for brain metastases by Zindler, J, Beumer, R.J, Troost, E.G.C, Hoffmann, A.L, Compter, I, Jager, J, Eekers, D, Lambin, P

Get full text

PO-0786: Can we derive the radiation target volume for moving lesions from 3D-PET? by Troost, E.G.C, Kuder, L, Mix, M, Doll, C, Duncker-Rohr, V, Momm, F, Grosu, A.L, Nestle, U

Get full text

PO-1003: Clinical setup accuracy for fractionated stereotactic ablative body radiotherapy for vertebral metastases by Ong, C.L, Zindler, J.D, Swinnen, A.C.C, Troost, E.G.C, Willems, D, De Rooy, M, Wanders, R.G, Lambin, P, Van Baardwijk, A

Get full text

PO-0669: External validation of a survival model for stage III NSCLC: focus on similarities or differences? by Oberije, C, Deasy, J, Lievens, Y, Belderbos, J, Vandecasteele, K, Uyterlinde, W, Rimner, A, Troost, E.G.C, Lambin, P

Get full text

PO-0968: The effect of SUV discretization in PET Radiomics: the need for standardized methodology in tumor texture analysis by Leijenaar, R.T.H, Nalbantov, G, Carvalho, S, Van Elmpt, W.J.C, Troost, E.G.C, Boellaard, R, Aerts, H.J.W.L, Gillies, R.J, Lambin, P

Get full text

SP-0425: Molecular imaging as biomarker in future clinical trials: The proof of the pudding is in the eating by Kaanders, J.H.A.M, Hoeben, B.A.W, Troost, E.G.C, Bussink, J, Oyen, W.J.G

Get full text